133 related articles for article (PubMed ID: 26284582)
1. Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).
Mohamed AM; Balsat M; Thenoz M; Koering C; Payen-Gay L; Cheok M; Mortada H; Auboeuf D; Pinatel C; El-Hamri M; Dumontet C; Cros E; Flandrin-Gresta P; Nibourel O; Preudhomme C; Michallet M; Thomas X; Nicolini F; Solly F; Guyotat D; Campos L; Wattel E; Mortreux F
Oncotarget; 2016 Jan; 7(3):2889-909. PubMed ID: 26284582
[TBL] [Abstract][Full Text] [Related]
2. Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid Leukemia.
Jin P; Wang X; Jin Q; Zhang Y; Shen J; Jiang G; Zhu H; Zhao M; Wang D; Li Z; Zhou Y; Li W; Zhang W; Liu Y; Wang S; Jin W; Cao Y; Sheng G; Dong F; Wu S; Li X; Jin Z; He M; Liu X; Chen L; Zhang Y; Wang K; Li J
Cancer Res; 2024 May; 84(10):1583-1596. PubMed ID: 38417135
[TBL] [Abstract][Full Text] [Related]
3. Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Human Acute Myeloid Leukemia.
Boda AR; Liu AJ; Castro-Pando S; Whitfield BT; Molldrem JJ; Al-Atrash G; Di Francesco ME; Jones P; Ager CR; Curran MA
Cancer Res Commun; 2024 Mar; 4(3):911-918. PubMed ID: 38477596
[TBL] [Abstract][Full Text] [Related]
4. Differential Gene Regulatory Network Analysis between Azacitidine-Sensitive and -Resistant Cell Lines.
Park H; Miyano S
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542276
[TBL] [Abstract][Full Text] [Related]
5. Detection and targeting of splicing deregulation in pediatric acute myeloid leukemia stem cells.
van der Werf I; Mondala PK; Steel SK; Balaian L; Ladel L; Mason CN; Diep RH; Pham J; Cloos J; Kaspers GJL; Chan WC; Mark A; La Clair JJ; Wentworth P; Fisch KM; Crews LA; Whisenant TC; Burkart MD; Donohoe ME; Jamieson CHM
Cell Rep Med; 2023 Mar; 4(3):100962. PubMed ID: 36889320
[TBL] [Abstract][Full Text] [Related]
6. Genome-scale integration of transcriptome and metabolome unveils squalene synthase and dihydrofolate reductase as targets against AML cells resistant to chemotherapy.
Karakitsou E; Foguet C; Contreras Mostazo MG; Kurrle N; Schnütgen F; Michaelis M; Cinatl J; Marin S; Cascante M
Comput Struct Biotechnol J; 2021; 19():4059-4066. PubMed ID: 34377370
[TBL] [Abstract][Full Text] [Related]
7. A novel approach to overcome drug resistance in acute myeloid leukemia.
Mazewski C; Platanias LC
Haematologica; 2023 Nov; 108(11):2889-2890. PubMed ID: 37165841
[No Abstract] [Full Text] [Related]
8. The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia.
Miliara S; Cozzi E; Zhong X; Chan I; Ekwall K; Lehmann S; Lennartsson A; Bartek J; Kanellis DC
Leukemia; 2024 Mar; 38(3):663-666. PubMed ID: 38036629
[No Abstract] [Full Text] [Related]
9. The exosome controls alternative splicing by mediating the gene expression and assembly of the spliceosome complex.
Zhang L; Wan Y; Huang G; Wang D; Yu X; Huang G; Guo J
Sci Rep; 2015 Aug; 5():13403. PubMed ID: 26306464
[TBL] [Abstract][Full Text] [Related]
10. Connecting the dots: chromatin and alternative splicing in EMT.
Warns JA; Davie JR; Dhasarathy A
Biochem Cell Biol; 2016 Feb; 94(1):12-25. PubMed ID: 26291837
[TBL] [Abstract][Full Text] [Related]
11. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.
Sveen A; Kilpinen S; Ruusulehto A; Lothe RA; Skotheim RI
Oncogene; 2016 May; 35(19):2413-27. PubMed ID: 26300000
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of pre-mRNA splicing.
Hang J; Wan R; Yan C; Shi Y
Science; 2015 Sep; 349(6253):1191-8. PubMed ID: 26292705
[TBL] [Abstract][Full Text] [Related]
13. Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid Leukemia.
Muppidi MR; Portwood S; Griffiths EA; Thompson JE; Ford LA; Freyer CW; Wetzler M; Wang ES
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S73-9. PubMed ID: 26297284
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells.
Larrue C; Saland E; Boutzen H; Vergez F; David M; Joffre C; Hospital MA; Tamburini J; Delabesse E; Manenti S; Sarry JE; Récher C
Blood; 2016 Feb; 127(7):882-92. PubMed ID: 26286850
[TBL] [Abstract][Full Text] [Related]
15. Structure of a yeast spliceosome at 3.6-angstrom resolution.
Yan C; Hang J; Wan R; Huang M; Wong CC; Shi Y
Science; 2015 Sep; 349(6253):1182-91. PubMed ID: 26292707
[TBL] [Abstract][Full Text] [Related]
16. The spliceosome is a therapeutic vulnerability in MYC-driven cancer.
Hsu TY; Simon LM; Neill NJ; Marcotte R; Sayad A; Bland CS; Echeverria GV; Sun T; Kurley SJ; Tyagi S; Karlin KL; Dominguez-Vidaña R; Hartman JD; Renwick A; Scorsone K; Bernardi RJ; Skinner SO; Jain A; Orellana M; Lagisetti C; Golding I; Jung SY; Neilson JR; Zhang XH; Cooper TA; Webb TR; Neel BG; Shaw CA; Westbrook TF
Nature; 2015 Sep; 525(7569):384-8. PubMed ID: 26331541
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management.
Garcia-Manero G
Am J Hematol; 2015 Sep; 90(9):831-41. PubMed ID: 26294090
[TBL] [Abstract][Full Text] [Related]
18. Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia.
Meggendorfer M; de Albuquerque A; Nadarajah N; Alpermann T; Kern W; Steuer K; Perglerová K; Haferlach C; Schnittger S; Haferlach T
Haematologica; 2015 Dec; 100(12):e487-90. PubMed ID: 26294738
[No Abstract] [Full Text] [Related]
19. Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients.
Zuffa E; Franchini E; Papayannidis C; Baldazzi C; Simonetti G; Testoni N; Abbenante MC; Paolini S; Sartor C; Parisi S; Marconi G; Cattina F; Bochicchio MT; Venturi C; Ottaviani E; Cavo M; Martinelli G
Oncotarget; 2015 Oct; 6(31):31284-94. PubMed ID: 26384303
[TBL] [Abstract][Full Text] [Related]
20. An alternative splicing event amplifies evolutionary differences between vertebrates.
Gueroussov S; Gonatopoulos-Pournatzis T; Irimia M; Raj B; Lin ZY; Gingras AC; Blencowe BJ
Science; 2015 Aug; 349(6250):868-73. PubMed ID: 26293963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
